Literature DB >> 10902855

Craniofacial hemangiopericytoma associated with oncogenic osteomalacia: case report.

F A Sandhu1, R L Martuza.   

Abstract

A craniofacial hemangiopericytoma associated with oncogenic osteomalacia is described and the literature is reviewed. A 46 year-old male with multiple fractures and hypophosphatemia was found to have a craniofacial mass extending from the right ethmoid sinus into the right frontal lobe. Initial detection of the tumor was made with an 111Indium-pentreotide scan (Octreoscan). Gross total resection of the tumor was achieved and the patient received postoperative radiation therapy. One year after surgery, the patient remains free of tumor with significant increase in bone density and normal phosphate levels. This is the first report of a hemangiopericytoma invading the brain that was associated with paraneoplastic hypophosphatemia and osteomalacia. Also, this is the first reported detection of a hemangiopericytoma by an Octreoscan. Primary detection and secondary surveillance of hemangiopericytomas may be possible with serial Octreoscans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10902855     DOI: 10.1023/a:1006352106762

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  19 in total

1.  Retroperitoneal hemangiopericytoma associated with hypoglycemia and masculinization.

Authors:  J W HOWARD; P L DAVIS
Journal:  Del Med J       Date:  1959-02

2.  Haemangiopericytoma of the nose and paranasal sinuses.

Authors:  O P Chawla; V H Oswal
Journal:  J Laryngol Otol       Date:  1987-07       Impact factor: 1.469

3.  Hypertension due to a renin-secreting renal tumour.

Authors:  P W Robertson; A Klidjian; L K Harding; G Walters; M R Lee; A H Robb-Smith
Journal:  Am J Med       Date:  1967-12       Impact factor: 4.965

4.  Hemangiopericytoma. An analysis of 106 cases.

Authors:  F M Enzinger; B H Smith
Journal:  Hum Pathol       Date:  1976-01       Impact factor: 3.466

5.  Noninvasive differentiation of meningiomas from other brain tumours using combined 111Indium-octreotide/99mtechnetium-DTPA brain scintigraphy.

Authors:  A Barth; A R Haldemann; J C Reubi; N Godoy; H Rösler; J A Kinser; R W Seiler
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

6.  Somatostatin receptor imaging in CNS tumours using 111In-octreotide.

Authors:  C L Maini; R Sciuto; A Tofani; A Ferraironi; C M Carapella; E Occhipinti; M Mottolese; M Crecco
Journal:  Nucl Med Commun       Date:  1995-09       Impact factor: 1.690

7.  Hemangiopericytoma-like intranasal tumors. A clinicopathologic study of 23 cases.

Authors:  J Compagno; V J Hyams
Journal:  Am J Clin Pathol       Date:  1976-10       Impact factor: 2.493

8.  Hemangiopericytoma of the central nervous system: a review of 94 cases.

Authors:  H Mena; J L Ribas; G H Pezeshkpour; D N Cowan; J E Parisi
Journal:  Hum Pathol       Date:  1991-01       Impact factor: 3.466

9.  Immunohistochemical characteristics of haemangiopericytic meningiomas: comparison with typical meningiomas, haemangioblastomas and haemangiopericytomas from extracranial sites.

Authors:  T H Moss
Journal:  Neuropathol Appl Neurobiol       Date:  1987 Nov-Dec       Impact factor: 8.090

10.  The pathology of head and neck tumors: vasoformative tumors, part 9B.

Authors:  J G Batsakis; D H Rice
Journal:  Head Neck Surg       Date:  1981 Mar-Apr
View more
  9 in total

1.  Striking pathology gold: a singular experience with daily reverberations: sinonasal hemangiopericytoma (glomangiopericytoma) and oncogenic osteomalacia.

Authors:  Margaret Brandwein-Gensler; Gene P Siegal
Journal:  Head Neck Pathol       Date:  2012-03-20

2.  Using (18)F-FDG PET/CT to Detect an Occult Mesenchymal Tumor Causing Oncogenic Osteomalacia.

Authors:  Hyo Jung Seo; Yun Jung Choi; Hyun Jeong Kim; Yong Hyu Jeong; Arthur Cho; Jae Hoon Lee; Mijin Yun; Jong Doo Lee; Won Jun Kang
Journal:  Nucl Med Mol Imaging       Date:  2011-07-14

3.  Oncogenic osteomalacia due to phosphaturic mesenchymal tumor of the craniofacial sinuses.

Authors:  Giuseppe Guglielmi; Michele Bisceglia; Alfredo Scillitani; Andrew L Folpe
Journal:  Clin Cases Miner Bone Metab       Date:  2011-05

4.  Varied presentation of sinonasal phosphaturic mesenchymal tumour: report of a case series with follow-up.

Authors:  Regi Kurien; Vedantam Rupa; Meera Thomas
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-16       Impact factor: 2.503

Review 5.  Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck.

Authors:  Hiba Qari; Aya Hamao-Sakamoto; Clay Fuselier; Yi-Shing Lisa Cheng; Harvey Kessler; John Wright
Journal:  Head Neck Pathol       Date:  2015-11-14

6.  Congenital sucrase-isomaltase deficiency presenting with failure to thrive, hypercalcemia, and nephrocalcinosis.

Authors:  John W Belmont; Barbara Reid; William Taylor; Susan S Baker; Warren H Moore; Michael C Morriss; Susan M Podrebarac; Nancy Glass; I David Schwartz
Journal:  BMC Pediatr       Date:  2002-04-25       Impact factor: 2.125

Review 7.  Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review.

Authors:  Huanwen Wu; Marilyn M Bui; Lian Zhou; Dongmei Li; Hui Zhang; Dingrong Zhong
Journal:  Mod Pathol       Date:  2018-09-11       Impact factor: 7.842

8.  Tumor induced osteomalacia in head and neck region: single center experience and systematic review.

Authors:  Ravikumar Shah; Anurag R Lila; Ramteke-Swati Jadhav; Virendra Patil; Abhishek Mahajan; Sushil Sonawane; Puja Thadani; Anil Dcruz; Prathamesh Pai; Munita Bal; Subhada Kane; Nalini Shah; Tushar Bandgar
Journal:  Endocr Connect       Date:  2019-10       Impact factor: 3.335

9.  Successful Treatment of Tumor-Induced Osteomalacia by Multidisciplinary Therapy with Radiation to Intracranial Fibromyxoid Tumor.

Authors:  Mariangela Massaccesi; Francesco Miccichè; Mario Rigante; Gianluigi Petrone; Elisabetta Lepre; Maria Antonietta Gambacorta; Vincenzo Valentini
Journal:  Case Rep Endocrinol       Date:  2021-06-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.